US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...

Business leaders from major Hoosier companies say they are trying to navigate the uncertain trade environment created by ...

Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...

A bold move by US President Donald Trump to slash the cost of prescription drugs in America has sent shockwaves through the ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

Announcement pressures pharma stocks on worries profits will be hit if they have to cut prices in US. Read more at ...

The package revives President Donald Trump’s much-maligned Most Favored Nation rule but goes further into the private markets ...

Trump’s drug pricing order sparks global pharma sell-off as industry warns of stifled innovation and revenue loss in key US ...

Eli Lil­ly is set to pay up to $415 million in an ALS deal ... Takeda pledged $30 billion in U.S. manufacturing and argued against President Donald Trump’s ‘most favored nations’ proposal. Gilead ...

Shares of pharmaceutical companies fell across the world after US President Donald Trump said he planned to order a cut in US ...

PhRMA, which gave $1 million to Trump's inaugural fund, warned against parts of Trump's drug pricing executive order.

President Donald Trump's second term in office has been challenging for investors, at least so far. Trump imposed sweeping ...